How Common Is Subsequent Central Nervous System Toxicity in Asymptomatic Patients With Haematologic Malignancy and Supratherapeutic Voriconazole Serum Levels?

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2016.12.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Serum VEGF-A Concentrations in Patients With Central Nervous System (CNS) Tumors

PLoS ONE
Multidisciplinary
2018English

Dapsone-Associated Methaemoglobinaemia in Patients With a Haematologic Malignancy

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2010English

Central Nervous System Toxicity of Interferon

Progress in Tumor Research
Cancer ResearchOncology
English

Chronic Viral Infection and Primary Central Nervous System Malignancy

Journal of NeuroImmune Pharmacology
NeuroscienceAllergyImmunologyPharmacology
2010English

Central Nervous System Toxicity of Interferon

British Journal of Cancer
Cancer ResearchOncology
1983English

Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy With Echinocandins

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Dementia in Patients With Central Nervous System Infection

Journal of Nihon University Medical Association
2018English

Treatment of Central Nervous System Lymphoma in Rats With Intraventricular Rituximab and Serum

International Journal of Hematology
Hematology
2010English

Treatment Outcomes and Late Toxicities in Patients With Embryonal Central Nervous System Tumors

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy